{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:52:43Z","timestamp":1772243563234,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T00:00:00Z","timestamp":1442188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T00:00:00Z","timestamp":1442188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U24CA143835"],"award-info":[{"award-number":["U24CA143835"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Blanton-Davis Ovarian Cancer Research Program"},{"name":"the Asian Foundation for Cancer Research"},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81101673,81472761"],"award-info":[{"award-number":["81101673,81472761"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tianjin Science and Technology Committee Foundation","award":["14JCYBJC25300"],"award-info":[{"award-number":["14JCYBJC25300"]}]},{"name":"Tianjin Science and Technology Committee Foundation","award":["14RCGFSY00148"],"award-info":[{"award-number":["14RCGFSY00148"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin J Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s40880-015-0049-z","type":"journal-article","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T11:35:39Z","timestamp":1442230539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["miR-506: a regulator of chemo-sensitivity through suppression of the RAD51-homologous recombination axis"],"prefix":"10.1186","volume":"34","author":[{"given":"Guoyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengxia","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,14]]},"reference":[{"issue":"1","key":"49_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5\u201329.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"49_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5732\/cjc.014.10273","volume":"34","author":"M Devouassoux-Shisheboran","year":"2015","unstructured":"Devouassoux-Shisheboran M, Genestie C. Pathobiology of ovarian carcinomas. Chin J Cancer. 2015;34(1):50\u20135.","journal-title":"Chin J Cancer"},{"issue":"7353","key":"49_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474(7353):609\u201315.","journal-title":"Nature"},{"issue":"1","key":"49_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrc3181","volume":"12","author":"R Roy","year":"2011","unstructured":"Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer. 2011;12(1):68\u201378.","journal-title":"Nat Rev Cancer"},{"key":"49_CR5","doi-asserted-by":"publisher","unstructured":"Liu G, Yang D, Rupaimoole R, Pecot CV, Sun Y, Mangala LS, et al. Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers. J Natl Cancer Inst. 2015;107(7). doi:\n                    10.1093\/jnci\/djv108","DOI":"10.1093\/jnci\/djv108."},{"issue":"2","key":"49_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ccr.2012.12.020","volume":"23","author":"D Yang","year":"2013","unstructured":"Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot CV, et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell. 2013;23(2):186\u201399.","journal-title":"Cancer Cell"},{"issue":"3","key":"49_CR7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/path.4348","volume":"233","author":"G Liu","year":"2014","unstructured":"Liu G, Sun Y, Ji P, Li X, Cogdell D, Yang D, et al. MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4\/6-FOXM1 axis in ovarian cancer. J Pathol. 2014;233(3):308\u201318.","journal-title":"J Pathol"},{"issue":"1","key":"49_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5732\/cjc.014.10284","volume":"34","author":"Y Sun","year":"2015","unstructured":"Sun Y, Guo F, Bagnoli M, Xue FX, Sun BC, Shmulevich I, et al. Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer. Chin J Cancer. 2015;34(1):28\u201340.","journal-title":"Chin J Cancer"},{"issue":"7","key":"49_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0968-0004(98)01232-8","volume":"23","author":"P Baumann","year":"1998","unstructured":"Baumann P, West SC. Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. Trends Biochem Sci. 1998;23(7):247\u201351.","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"49_CR10","doi-asserted-by":"publisher","first-page":"e27183","DOI":"10.1371\/journal.pone.0027183","volume":"6","author":"S Quiros","year":"2011","unstructured":"Quiros S, Roos WP, Kaina B. Rad51 and BRCA2\u2014new molecular targets for sensitizing glioma cells to alkylating anticancer drugs. PLoS One. 2011;6(11):e27183.","journal-title":"PLoS One"},{"issue":"3","key":"49_CR11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1124\/jpet.110.173146","volume":"335","author":"MS Tsai","year":"2010","unstructured":"Tsai MS, Kuo YH, Chiu YF, Su YC, Lin YW. Down-regulation of Rad51 expression overcomes drug resistance to gemcitabine in human non-small-cell lung cancer cells. J Pharmacol Exp Ther. 2010;335(3):830\u201340.","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"49_CR12","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/jgm.753","volume":"7","author":"M Ito","year":"2005","unstructured":"Ito M, Yamamoto S, Nimura K, Hiraoka K, Tamai K, Kaneda Y. Rad51 siRNA delivered by HVJ envelope vector enhances the anti-cancer effect of cisplatin. J Gene Med. 2005;7(8):1044\u201352.","journal-title":"J Gene Med"},{"issue":"6","key":"49_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.bcp.2011.12.022","volume":"83","author":"Z Yang","year":"2012","unstructured":"Yang Z, Waldman AS, Wyatt MD. Expression and regulation of RAD51 mediate cellular responses to chemotherapeutics. Biochem Pharmacol. 2012;83(6):741\u20136.","journal-title":"Biochem Pharmacol"},{"issue":"7035","key":"49_CR14","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005;434(7035):917\u201321.","journal-title":"Nature"},{"issue":"7","key":"49_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.5732\/cjc.011.10111","volume":"30","author":"A Chen","year":"2011","unstructured":"Chen A. PARP inhibitors: its role in treatment of cancer. Chin J Cancer. 2011;30(7):463\u201371.","journal-title":"Chin J Cancer"},{"issue":"14","key":"49_CR16","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.2011.1456","volume":"306","author":"D Yang","year":"2011","unstructured":"Yang D, Khan S, Sun Y, Hess K, Shmulevich I, Sood AK, et al. Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA. 2011;306(14):1557\u201365.","journal-title":"JAMA"},{"issue":"4","key":"49_CR17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jama.2012.20","volume":"307","author":"KL Bolton","year":"2012","unstructured":"Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, et al. Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA. 2012;307(4):382\u201390.","journal-title":"JAMA"},{"issue":"13","key":"49_CR18","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.2217\/pgs.12.137","volume":"13","author":"G Liu","year":"2012","unstructured":"Liu G, Yang D, Sun Y, Shmulevich I, Xue F, Sood AK, et al. Differing clinical impact of BRCA1 and BRCA2 mutations in serous ovarian cancer. Pharmacogenomics. 2012;13(13):1523\u201335.","journal-title":"Pharmacogenomics"}],"container-title":["Chinese Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40880-015-0049-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40880-015-0049-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40880-015-0049-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40880-015-0049-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T16:26:02Z","timestamp":1589559962000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancercommun.biomedcentral.com\/articles\/10.1186\/s40880-015-0049-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,14]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1186\/s40880-015-0049-z","relation":{},"ISSN":["1944-446X"],"issn-type":[{"value":"1944-446X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,14]]},"assertion":[{"value":"29 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"44"}}